ArticleJournal of diabetes2026
Triangulating the Skeletal Safety of SGLT2 Inhibitors in Diabetes.
Bin Huang, Shujie Yu, Anran Su, Yi Zheng, Yue Teng, Wei Wang
Abstract readLetter
In one paragraphArticle in Journal of diabetes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Bin HuangDepartment of Endocrinology and Metabolism, Centre for Leading Medicine and Advanced Technologies of IHM, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.ORCID https://orcid.org/0000-0002-8878-828X Shujie YuDepartment of Endocrinology and Metabolism, Centre for Leading Medicine and Advanced Technologies of IHM, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Anran SuDepartment of Endocrinology and Metabolism, Centre for Leading Medicine and Advanced Technologies of IHM, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Yi ZhengDepartment of Endocrinology and Metabolism, Centre for Leading Medicine and Advanced Technologies of IHM, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Yue TengDepartment of Endocrinology and Metabolism, Centre for Leading Medicine and Advanced Technologies of IHM, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Wei WangDepartment of Endocrinology and Metabolism, Centre for Leading Medicine and Advanced Technologies of IHM, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.ORCID https://orcid.org/0000-0002-4123-8280 Funding
Anhui Province Science Foundation for Youths 2308085QH261Diabetes and Metabolism Research Fund Z-2017-26-2202-2Health Commission of Anhui Province Research Project AHWJ2023BAc20085National Natural Science Foundation of China 32271176National Natural Science Foundation of China 82501013Research Funds of Centre for Leading Medicine and Advanced Technologies of IHM 2025IHM01030USTC Research Funds of the Double First-Class Initiative YD9110002085
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID42649128
PMCPMC13518367
What OpenQuestion holds
Textmetadata
Read underepoch 390